Expression of co-stimulatory molecules CD80 and CD86 is altered in CD14+HLA-DR+ monocytes from patients with Chagas disease following induction by Trypanosoma cruzi recombinant antigens

被引:9
|
作者
de Araujo Soares, Ana Karine [1 ]
Feitosa Neves, Patricia Areias [1 ]
Aureliano de Melo Cavalcanti, Maria da Gloria [2 ,3 ]
Marinho, Silvia Martins [2 ,3 ]
de Oliveira Junior, Wilson [2 ,3 ]
de Souza, Joelma Rodrigues [4 ]
Barros de Lorena, Virginia Maria [1 ,3 ]
Gomes, Yara de Miranda [1 ,3 ]
机构
[1] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil
[2] Univ Pernambuco, Pronto Socorro Cardiol Pernambuco PROCAPE, Recife, PE, Brazil
[3] Fundacao Oswaldo Cruz, Programa Integrado Doenca Chagas, Rio De Janeiro, RJ, Brazil
[4] Univ Fed Paraiba, Dept Fisiol & Patol, Joao Pessoa, Paraiba, Brazil
关键词
Chagas disease; Immune response; Recombinant antigens; INDETERMINATE; CYTOKINES; CELLS;
D O I
10.1590/0037-8682-0149-2016
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Introduction: The relationships between monocytes and lymphocytes through MHC class II molecules and costimulatory, are of utmost importance for the production of an efficient immune response. In this work, we assessed the expression of surface molecules CD80 and CD86 on CD14(+)HLA-DR+ monocytes from patients with Chagas disease. Methods: The study population consisted of 31 patients with chronic clinical forms of Chagas disease. Patient blood samples were cultured in the presence of recombinant cytoplasmic repetitive antigen (CRA) and flagellar repetitive antigen (FRA). Results: We found considerable differences in the expression profile of surface molecules involved in antigen presentation. Conclusions: CRA and FRA may contribute to host immune response evasion by Trypanozoma cruzi.
引用
收藏
页码:632 / 636
页数:5
相关论文
共 32 条
  • [1] The differential role of CD86 and CD80 co-stimulatory molecules in the induction and the effector phases of contact hypersensitivity
    Nuriya, S
    Yagita, H
    Okumura, K
    Azuma, M
    INTERNATIONAL IMMUNOLOGY, 1996, 8 (06) : 917 - 926
  • [2] Expression of co-stimulatory molecules, CD80 and CD86, on peripheral blood T cells in lupus patients.
    Abe, K
    Seki, M
    Ushiyama, C
    Fukazawa, T
    Yasuda, M
    Ogaki, M
    Takasaki, Y
    Hasimoto, H
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1331 - 1331
  • [3] Both CD80 and CD86 co-stimulatory molecules regulate allergic pulmonary inflammation
    Mark, DA
    Donovan, CE
    De Sanctis, GT
    Krinzman, SJ
    Kobzik, L
    Linsley, PS
    Sayegh, MH
    Lederer, J
    Perkins, DL
    Finn, PW
    INTERNATIONAL IMMUNOLOGY, 1998, 10 (11) : 1647 - 1655
  • [4] Expression of the co-stimulatory molecules CD58, CD80, and CD86 on human intestinal epithelial cells.
    Framson, P
    Lee, L
    Hershberg, R
    GASTROENTEROLOGY, 1998, 114 (04) : A979 - A979
  • [5] Differential effects of iron deficiency on the expression of CD80 and CD86 co-stimulatory molecules in murine spleen cells
    Kuvibidila, SR
    Porretta, C
    FASEB JOURNAL, 2002, 16 (04): : A622 - A622
  • [6] Interferon-β up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes:: significance for treatment of multiple sclerosis
    Marckmann, S
    Wiesemann, E
    Hilse, R
    Trebst, C
    Stangel, M
    Windhagen, A
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 138 (03): : 499 - 506
  • [7] Lower percentages of monocytes with CD80, CD86 and HLA-DR molecule expression in pediatric cancer
    Wlodzimierz Luczynski
    Anna Stasiak-Barmuta
    Maryna Krawczuk-Rybak
    Cancer Immunology, Immunotherapy, 2004, 53 : 1049 - 1050
  • [8] Lower percentages of monocytes with CD80, CD86 and HLA-DR molecule expression in pediatric cancer
    Luczynski, W
    Stasiak-Barmuta, A
    Krawczuk-Rybak, M
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (11) : 1049 - 1050
  • [9] Preclinical imaging of the co-stimulatory molecules CD80 and CD86 with indium-111-labeled belatacept in atherosclerosis
    Meletta, Romana
    Herde, Adrienne Mueller
    Dennler, Patrick
    Fischer, Eliane
    Schibli, Roger
    Kraemer, Stefanie D.
    EJNMMI RESEARCH, 2016, 6 : 1 - 12
  • [10] Preclinical imaging of the co-stimulatory molecules CD80 and CD86 with indium-111-labeled belatacept in atherosclerosis
    Romana Meletta
    Adrienne Müller Herde
    Patrick Dennler
    Eliane Fischer
    Roger Schibli
    Stefanie D. Krämer
    EJNMMI Research, 6